Cerus
CERS
#7757
Rank
C$0.44 B
Marketcap
C$2.32
Share price
-0.59%
Change (1 day)
9.12%
Change (1 year)

Earnings for Cerus (CERS)

Earnings in 2025 (TTM): -C$10.25 Million

According to Cerus's latest financial reports the company's current earnings are C$0.19 Billion. In 2024 the company made an earning of -C$16.31 Million, an increase over its 2023 earnings that were of -C$39.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$10.25 Million-37.18%
2024 -C$16.31 Million-58.95%
2023 -C$39.72 Million-20.74%
2022 -C$50.11 Million-25.7%
2021 -C$67.44 Million-11.99%
2020 -C$76.62 Million-14%
2019 -C$89.1 Million21.73%
2018 -C$73.19 Million-0.65%
2017 -C$73.67 Million-10.96%
2016 -C$82.74 Million4.24%
2015 -C$79.38 Million50.99%
2014 -C$52.57 Million-10.08%
2013 -C$58.47 Million184.13%
2012 -C$20.58 Million-7.91%
2011 -C$22.35 Million
2009 -C$31.56 Million-24.69%
2008 -C$41.9 Million-25.2%
2007 -C$56.02 Million330.54%
2006 -C$13.02 Million1.49%
2005 -C$12.82 Million-61.02%
2004 -C$32.89 Million
2002 -C$81.36 Million10.02%
2001 -C$73.95 Million34.25%
2000 -C$55.08 Million61.02%
1999 -C$34.21 Million-18.81%
1998 -C$42.14 Million93.08%
1997 -C$21.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
C$4.48 B-45,284.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
C$20.06 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.33 B-3,453.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$13.03 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA